Retrospective Cohort Study on the Predictive Value of Primary Non-response to Initial Biologic for Future Biologic Use in Patients with Inflammatory Bowel Disease

By sjmartinez • January 5, 2025

Krishna M, Spartz EJ, Maas L, Cusumano V, Sharma S, Limketkai B, Parian A. Retrospective Cohort Study on the Predictive Value of Primary Non-response to Initial Biologic for Future Biologic Use in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2025 Jan 4. doi: 10.1007/s10620-024-08816-9. Epub ahead of print. PMID: 39755922.

Tags: Biologics, Digestive Diseases, Fellow, Primary non-response, Publications, response, Secondary loss of response, Tumor necrosis factor inhibitor

Oral contraceptive pill-induced esophagitis: a rare cause of pill esophagitis in a Rwandan woman

Bensen GP, Bryan MR, Nishimwe E, Nguyen BS, Chudy-Onwugaje K. Oral contraceptive pill-induced esophagitis: a rare cause of pill esophagitis in a Rwandan woman. Oxf[...]

JPEN Journal Club 92. Adjusting randomized trials

Koretz RL. JPEN Journal Club 92. Adjusting randomized trials. JPEN J Parenter Enteral Nutr. 2025 Mar 31. doi: 10.1002/jpen.2750. Epub ahead of print. PMID: 40162714.

Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial

Singh S, Nguyen JD, Fudman DI, Gerich ME, Shah SA, Hudesman D, McConnell RA, Lukin DJ, Flynn AD, Hwang C, Sprung B, Gaidos JKJ, Mattar[...]